Intestinal Polyps

3

Review clinical trials related to Intestinal Polyps. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Recurrence After Gastric and Intestinal Polyp Resection

This is a retrospective and prospective cohort study designed to evaluate the recurrence rate and identify risk factors after endoscopic resection of gastric and intestinal polyps. BACKGROUND: Gastric and intestinal polyps are common digestive diseases with potential for malignant transformation. Although endoscopic resection is the standard treatment, recurrence rates range from 10-50%, and the mechanisms and risk factors remain unclear. OBJECTIVES: Primary: To assess short-term (1-year) and long-term (3-year) recurrence rates after endoscopic polyp resection Secondary: To identify independent risk factors and develop a recurrence risk prediction model DESIGN: Mixed retrospective-prospective cohort study * Retrospective cohort: Patients who underwent polyp resection from 2021-2022, with follow-up data through 2024 * Prospective cohort: Patients enrolled from 2024-2025, with standardized follow-up through 2028 SETTING: Single tertiary referral center with \>10,000 endoscopic polyp resections performed since 2021 PARTICIPANTS: Approximately 1,600-1,800 adult patients (≥18 years) who underwent complete endoscopic resection of gastric or intestinal polyps FOLLOW-UP: * Short-term: 1 year post-resection (±2 months) * Long-term: 3 years post-resection (±3 months) MAIN OUTCOME: Recurrence rate defined as new polyp detection at original or different sites during endoscopic surveillance POTENTIAL RISK FACTORS: Patient demographics, polyp characteristics (size, number, location, pathology), resection method, Helicobacter pylori status, lifestyle factors, and medication use EXPECTED IMPACT: Results will inform personalized surveillance strategies and optimize resource allocation for post-polypectomy follow-up.

Participants needed: 2,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: LanZhou UniversityUpdated: Jun 9, 2026Locations: 1Duration: 3 Years
Eligibility criteria

Age 18 years or older [+6]

Hereditary polyposis syndromes (familial adenomatous polyposis, Lynch syndrome,... [+8]

Status: Recruiting

Efficacy of CAD in Screening Colonoscopy to Reduce the Risk of Advanced Adenoma at 3 Years.

The occurrence of interval cancers after colonoscopy raises the possibility of missed lesions. High- performance computer aided diagnosis (CAD) systems have been specially designed for the detection of colorectal lesions (CAD for detection is named CADe). The use of CADe improves adenoma detection in screening colonoscopy. The potential of CADe system in reducing the rate of progression to advanced polyps or interval cancer between two colonoscopies remains still uncertain.

Participants needed: 592
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University Hospital, BordeauxUpdated: Mar 16, 2026Locations: 13
Eligibility criteria

Patients over 18 years of age with indication for colonoscopy as part of a scree... [+2]

Failed complete colonoscopy, defined by the absence of cecal intubation and/or t... [+8]

Status: Not yet recruiting

Effect of Non-invasive Neuromodulation on the Quality of Intestinal Cleansing

To clarify whether non-invasive neuromodulation for assisted bowel preparation can improve the quality of bowel preparation, to explore the possible mechanisms by which TEA improves the quality of bowel preparation, and to assess its safety, as well as subjects' tolerance, compliance and satisfaction.

Participants needed: 270
Trial details
Age: 18-78Biological sex: AllType: InterventionalSponsor: Shanghai East HospitalUpdated: Dec 18, 2025Locations: 1
Eligibility criteria

18 to 78 years of age, male or female; [+2]

Severe cardiac, cerebral, pulmonary, or renal complications or a history of acut... [+4]